The year 1982 was pivotal for Paul Volberding, MD. In the early days of the AIDS crisis, he was a talented research fellow who was getting ready to help launch San Francisco General Hospital & Trauma Center’s Ward 86, which would become the world’s first HIV/AIDS outpatient clinic. It opened its doors the following year.
July 18, 2012
July 11, 2012
A declaration calling for global support to end the AIDS epidemic was announced on July 10 by the International AIDS Society, with key support from the University of California, San Francisco (UCSF).
July 11, 2012
The first U.S. meeting of the International AIDS Conference in more than two decades will be held later this month in Washington, DC, and Bay Area reporters got a preview of what UCSF researchers will present when they convene at the nation's capitol.
July 11, 2012
On the eve of the XIX International AIDS Conference in Washington, D.C., UCSF's Jay Levy paused recently to reflect on HIV — a disease that has defined a generation, continues to plague the world and may yet be vanquished.
July 02, 2012
UCSF teams are working hard to achieve a collective fundraising goal of $55,000 in AIDS Walk San Francisco, which is on July 15.
March 23, 2012
To effectively confront the HIV/AIDS epidemic in Oakland, the medical community needs to connect with African-American young men, who are a particularly vulnerable group of individuals who may not know they are at high risk and may not be receiving the information they need to protect themselves.
February 17, 2012
Paul Volberding, MD, one of the world's leading experts on treatment for patients infected with HIV, the AIDS virus, became the new director of the AIDS Research Institute (ARI) at UCSF on Feb. 13.
February 10, 2012
Scientists at the San Francisco VA Medical Center and the University of California, San Francisco have published a study showing that one of the most effective and commonly prescribed antiretroviral medications for HIV/AIDS, tenofovir, is associated with a significant risk of kidney damage and chronic kidney disease that increases over time. See accompanying news release, Tenofovir, Leading HIV Medication, Linked with Risk of Kidney Damage.
December 14, 2011
UCSF and its affiliate Blood Systems Research Institute have been awarded nearly $33 million in research contracts for four projects as part of a major new research initiative designed to improve the safety and effectiveness of blood transfusions in the United States and abroad.
December 02, 2011
As physicians working on the frontlines of HIV/AIDS since its start 30 years ago near retirement, UCSF is looking to attract and train the next generation of doctors to specialize in HIV/AIDS medicine.